Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Fraternal Order of Police, Miami Lodge 20, Insurance Trust Fund v. Allergan, Inc.
Case Number:
2:17-cv-00755
Court:
Nature of Suit:
Multi Party Litigation:
Class Action
Judge:
Firms
Companies
Sectors & Industries:
-
January 08, 2018
Restasis Antitrust Suits Paused For MDL Panel Review
A Texas federal court on Friday stayed a series of lawsuits accusing Allergan PLC of violating antitrust laws to keep generics for the dry-eye medication Restasis off the market, until the Judicial Panel on Multidistrict Litigation decides whether the cases should be combined.
-
December 21, 2017
Allergan Seeks To Pause Antitrust Suits Pending MDL Call
Allergan Inc. asked a Texas federal judge on Thursday to pause several suits alleging the company delayed the launch of generic versions of its dry-eye medication Restasis, in part by transferring patents to a Native American tribe, until a decision is made about forming a multidistrict litigation.
-
November 28, 2017
Allergan Hit With Antitrust Suit Over Deal With Tribe
Allergan Inc. was hit with a lawsuit on Monday by a proposed class of indirect purchasers who bought the dry-eye treatment Restasis at allegedly "supracompetitive prices," saying the company entered into a deal with a Native American tribe to avoid patent invalidation.